BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

383 related articles for article (PubMed ID: 28710602)

  • 21. Synthesis and preliminary biological evaluation of 20-epi-eldecalcitol [20-epi-1alpha,25-dihydroxy-2beta-(3-hydroxypropoxy)vitamin D3: 20-epi-ED-71].
    Hatakeyama S; Yoshino M; Eto K; Takahashi K; Ishihara J; Ono Y; Saito H; Kubodera N
    J Steroid Biochem Mol Biol; 2010 Jul; 121(1-2):25-8. PubMed ID: 20304058
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Operculina turpethum extract inhibits growth and proliferation by inhibiting NF-κB, COX-2 and cyclin D1 and induces apoptosis by up regulating P53 in oral cancer cells.
    Arora R; Bharti V; Gaur P; Aggarwal S; Mittal M; Das SN
    Arch Oral Biol; 2017 Aug; 80():1-9. PubMed ID: 28351666
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MART-10, a novel vitamin D analog, inhibits head and neck squamous carcinoma cells growth through cell cycle arrest at G0/G1 with upregulation of p21 and p27 and downregulation of telomerase.
    Chiang KC; Yeh CN; Hsu JT; Chen LW; Kuo SF; Sun CC; Huang CC; Pang JH; Flanagan JN; Takano M; Kittaka A; Juang HH; Yang SW; Chen TC
    J Steroid Biochem Mol Biol; 2013 Nov; 138():427-34. PubMed ID: 24044969
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Squamous carcinoma cell lines fail to respond to 1,25-Dihydroxyvitamin D despite normal levels of the vitamin D receptor.
    Ratnam AV; Bikle DD; Su MJ; Pillai S
    J Invest Dermatol; 1996 Mar; 106(3):522-5. PubMed ID: 8648187
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Eldecalcitol replaces endogenous calcitriol but does not fully compensate for its action in vivo.
    Saito H; Harada S
    J Steroid Biochem Mol Biol; 2014 Oct; 144 Pt A():189-96. PubMed ID: 24291401
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oxysophocarpine Retards the Growth and Metastasis of Oral Squamous Cell Carcinoma by Targeting the Nrf2/HO-1 Axis.
    Liu R; Peng J; Wang H; Li L; Wen X; Tan Y; Zhang L; Wan H; Chen F; Nie X
    Cell Physiol Biochem; 2018; 49(5):1717-1733. PubMed ID: 30231242
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression of a dominant-negative mutant inhibitor-kappaBalpha of nuclear factor-kappaB in human head and neck squamous cell carcinoma inhibits survival, proinflammatory cytokine expression, and tumor growth in vivo.
    Duffey DC; Chen Z; Dong G; Ondrey FG; Wolf JS; Brown K; Siebenlist U; Van Waes C
    Cancer Res; 1999 Jul; 59(14):3468-74. PubMed ID: 10416612
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Selective inhibition of NF-κB suppresses bone invasion by oral squamous cell carcinoma in vivo.
    Furuta H; Osawa K; Shin M; Ishikawa A; Matsuo K; Khan M; Aoki K; Ohya K; Okamoto M; Tominaga K; Takahashi T; Nakanishi O; Jimi E
    Int J Cancer; 2012 Sep; 131(5):E625-35. PubMed ID: 22262470
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vesnarinone inhibits angiogenesis and tumorigenicity of human oral squamous cell carcinoma cells by suppressing the expression of vascular endothelial growth factor and interleukin-8.
    Harada K; Supriatno ; Yoshida H; Sato M
    Int J Oncol; 2005 Dec; 27(6):1489-97. PubMed ID: 16273203
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A secreted FGF-binding protein can serve as the angiogenic switch in human cancer.
    Czubayko F; Liaudet-Coopman ED; Aigner A; Tuveson AT; Berchem GJ; Wellstein A
    Nat Med; 1997 Oct; 3(10):1137-40. PubMed ID: 9334727
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Amphiregulin is a vitamin D3 target gene in squamous cell and breast carcinoma.
    Akutsu N; Bastien Y; Lin R; Mader S; White JH
    Biochem Biophys Res Commun; 2001 Mar; 281(4):1051-6. PubMed ID: 11237771
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neutralizing antibodies against epidermal growth factor and ErbB-2/neu receptor tyrosine kinases down-regulate vascular endothelial growth factor production by tumor cells in vitro and in vivo: angiogenic implications for signal transduction therapy of solid tumors.
    Petit AM; Rak J; Hung MC; Rockwell P; Goldstein N; Fendly B; Kerbel RS
    Am J Pathol; 1997 Dec; 151(6):1523-30. PubMed ID: 9403702
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role of NLRP3 inflammasome in 5-fluorouracil resistance of oral squamous cell carcinoma.
    Feng X; Luo Q; Zhang H; Wang H; Chen W; Meng G; Chen F
    J Exp Clin Cancer Res; 2017 Jun; 36(1):81. PubMed ID: 28637493
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Opposite effects of arsenic trioxide on the Nrf2 pathway in oral squamous cell carcinoma in vitro and in vivo.
    Zhang X; Su Y; Zhang M; Sun Z
    Cancer Lett; 2012 May; 318(1):93-8. PubMed ID: 22155346
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CARD9 downregulation suppresses the growth of oral squamous cell carcinoma by regulating NF-κB.
    Ye LJ; Zhou XC; Yin XJ; Shang Y; Xiao Y; Jiang YL; Wen XX
    Oral Dis; 2019 Nov; 25(8):1886-1896. PubMed ID: 31306536
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tanshinone IIA induces cell death via Beclin-1-dependent autophagy in oral squamous cell carcinoma SCC-9 cell line.
    Qiu Y; Li C; Wang Q; Zeng X; Ji P
    Cancer Med; 2018 Feb; 7(2):397-407. PubMed ID: 29316373
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Garcinol inhibits tumour cell proliferation, angiogenesis, cell cycle progression and induces apoptosis via NF-κB inhibition in oral cancer.
    Aggarwal S; Das SN
    Tumour Biol; 2016 Jun; 37(6):7175-84. PubMed ID: 26662963
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunocytochemical localization of fibroblast growth factor-1 (FGF-1) and FGF-2 in oral squamous cell carcinoma (SCC).
    Myoken Y; Myoken Y; Okamoto T; Sato JD; Takada K
    J Oral Pathol Med; 1994 Nov; 23(10):451-6. PubMed ID: 7532220
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anti-tumor activity of dehydroxymethylepoxyquinomicin against human oral squamous cell carcinoma cell lines in vitro and in vivo.
    Yasuda A; Kondo S; Nagumo T; Tsukamoto H; Mukudai Y; Umezawa K; Shintani S
    Oral Oncol; 2011 May; 47(5):334-9. PubMed ID: 21459660
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Vitamin D promotes the cisplatin sensitivity of oral squamous cell carcinoma by inhibiting LCN2-modulated NF-κB pathway activation through RPS3.
    Huang Z; Zhang Y; Li H; Zhou Y; Zhang Q; Chen R; Jin T; Hu K; Li S; Wang Y; Chen W; Huang Z
    Cell Death Dis; 2019 Dec; 10(12):936. PubMed ID: 31819048
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.